Asma Khalil: Important Reassurance for Women Who Become Pregnant after Taking GLP-1 Medicines
Asma Khalil, Professor and Director of the Fetal Medicine Unit at Liverpool Women’s NHS Foundation Trust, shared a post on LinkedIn about a paper she co-authored with colleagues published in Med:
”New research offers important reassurance for women who become pregnant after taking GLP-1 medicines such as Wegovy or Mounjaro.
Our study of more than 2.1 million pregnancies found no clearly detectable increase in adverse pregnancy outcomes following GLP-1 exposure around conception.
These findings are reassuring, but they do not mean GLP-1 medicines are proven safe during pregnancy, and current guidance still applies.”
Title: GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis
Authors: Francesco D’Antonio, Maria Elena Flacco, Lamberto Manzoli, Athina Samara, Asma Khalil
You can read the Full Article in Med.

Proceed to the video attached to the post.
Other articles featuring Asma Khalil on Fertility News.
-
Nov 21, 2026, 18:17Sean Lauber: Euploid and Live Birth Rates Vary Across PGT-A Labs
-
Nov 21, 2026, 18:13Your Next Career Opportunity in Reproductive Medicine – ASRM
-
Nov 21, 2026, 18:09Can Preeclampsia Increase Your Risk of Heart Disease Later in Life? – Preeclampsia Foundation
-
Nov 21, 2026, 18:05Natalie Tam: Officially a WEST Graduate
-
Nov 21, 2026, 18:02Lucy Froese: She Was Told to Expect Six Eggs, but They Collected 18
-
Nov 21, 2026, 17:57An Effective Regulatory Framework for Surrogacy, ALRC Report – The Fertility Society of Australia and New Zealand
-
Nov 21, 2026, 17:53Irfana Koita: Should Treatment Start With IUI or IVF?
-
Nov 21, 2026, 17:50Amit Mangal: India’s Biggest IVF Chain May Be Up for Sale
-
Nov 21, 2026, 17:48Sue Hammoud: Excited to Be Attending My 1st JPM Healthcare Week
